1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "2097132-94-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-112301


    RET Cancer
    Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. Pralsetinib (BLU-667) inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively.